X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Pfizer with Orchid Chemicals - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs ORCHID PHARMA LTD - Comparison Results

PFIZER    Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

ORCHID PHARMA LTD 
   Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER ORCHID PHARMA LTD PFIZER/
ORCHID PHARMA LTD
 
P/E (TTM) x 31.4 -0.1 - View Chart
P/BV x 5.0 0.1 6,923.6% View Chart
Dividend Yield % 0.7 0.0 -  

Financials

 PFIZER   ORCHID PHARMA LTD
EQUITY SHARE DATA
    PFIZER
Mar-18
ORCHID PHARMA LTD
Sep-13
PFIZER/
ORCHID PHARMA LTD
5-Yr Chart
Click to enlarge
High Rs2,365194 1,219.1%   
Low Rs1,62535 4,642.9%   
Sales per share (Unadj.) Rs430.3276.5 155.6%  
Earnings per share (Unadj.) Rs78.7-79.2 -99.4%  
Cash flow per share (Unadj.) Rs93.2-43.5 -214.5%  
Dividends per share (Unadj.) Rs20.000-  
Dividend yield (eoy) %1.00-  
Book value per share (Unadj.) Rs586.553.9 1,087.4%  
Shares outstanding (eoy) m45.7570.45 64.9%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x4.60.4 1,119.5%   
Avg P/E ratio x25.3-1.4 -1,753.5%  
P/CF ratio (eoy) x21.4-2.6 -812.4%  
Price / Book Value ratio x3.42.1 160.2%  
Dividend payout %25.40-   
Avg Mkt Cap Rs m91,2718,067 1,131.5%   
No. of employees `0002.62.8 93.9%   
Total wages/salary Rs m3,1432,527 124.4%   
Avg. sales/employee Rs Th7,484.86,956.1 107.6%   
Avg. wages/employee Rs Th1,195.0902.5 132.4%   
Avg. net profit/employee Rs Th1,369.1-1,993.0 -68.7%   
INCOME DATA
Net Sales Rs m19,68519,477 101.1%  
Other income Rs m1,143407 280.7%   
Total revenues Rs m20,82819,884 104.7%   
Gross profit Rs m5,0031,103 453.7%  
Depreciation Rs m6632,519 26.3%   
Interest Rs m45,227 0.1%   
Profit before tax Rs m5,479-6,236 -87.9%   
Minority Interest Rs m020 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0511 0.0%   
Tax Rs m1,878-125 -1,500.3%   
Profit after tax Rs m3,601-5,580 -64.5%  
Gross profit margin %25.45.7 448.9%  
Effective tax rate %34.32.0 1,707.6%   
Net profit margin %18.3-28.7 -63.8%  
BALANCE SHEET DATA
Current assets Rs m24,16711,014 219.4%   
Current liabilities Rs m9,54432,060 29.8%   
Net working cap to sales %74.3-108.1 -68.7%  
Current ratio x2.50.3 737.0%  
Inventory Days Days5595 58.1%  
Debtors Days Days2934 85.5%  
Net fixed assets Rs m9,51429,440 32.3%   
Share capital Rs m458705 64.9%   
"Free" reserves Rs m26,3752,043 1,291.2%   
Net worth Rs m26,8323,800 706.1%   
Long term debt Rs m259,018 0.3%   
Total assets Rs m36,90046,510 79.3%  
Interest coverage x1,305.5-0.2 -676,029.0%   
Debt to equity ratio x02.4 0.0%  
Sales to assets ratio x0.50.4 127.4%   
Return on assets %9.8-0.8 -1,285.4%  
Return on equity %13.4-146.9 -9.1%  
Return on capital %20.4-3.7 -546.7%  
Exports to sales %037.9 0.0%   
Imports to sales %022.6 0.0%   
Exports (fob) Rs mNA7,378 0.0%   
Imports (cif) Rs mNA4,406 0.0%   
Fx inflow Rs m227,513 0.3%   
Fx outflow Rs m1,4895,649 26.4%   
Net fx Rs m-1,4661,865 -78.6%   
CASH FLOW
From Operations Rs m3,3181,682 197.3%  
From Investments Rs m-2,383-9,860 24.2%  
From Financial Activity Rs m-1,1046,644 -16.6%  
Net Cashflow Rs m-169-1,535 11.0%  

Share Holding

Indian Promoters % 0.0 32.3 -  
Foreign collaborators % 63.9 0.0 -  
Indian inst/Mut Fund % 7.5 4.6 163.0%  
FIIs % 4.9 3.3 148.5%  
ADR/GDR % 0.0 4.6 -  
Free float % 23.7 55.3 42.9%  
Shareholders   85,207 84,811 100.5%  
Pledged promoter(s) holding % 0.0 54.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   IPCA LABS  NOVARTIS  DR. DATSONS LABS  MERCK LTD  GSK PHARMA  

Compare PFIZER With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Where Will the Two-Faced Market Go from Here?(Podcast)

The stock markets are very volatile these days. As the Tanushree Bannerjee, the co-head of research here at Equitymaster puts it, stock markets are two-faced.

Related Views on News

ORCHID PHARMA LTD Announces Quarterly Results (2QFY19); Net Profit Up 67.1% (Quarterly Result Update)

Jan 31, 2019 | Updated on Jan 31, 2019

For the quarter ended September 2018, ORCHID PHARMA LTD has posted a net profit of Rs 231 m (up 67.1% YoY). Sales on the other hand came in at Rs 1 bn (down 31.9% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

PFIZER Announces Quarterly Results (3QFY19); Net Profit Up 51.2% (Quarterly Result Update)

Jan 25, 2019 | Updated on Jan 25, 2019

For the quarter ended December 2018, PFIZER has posted a net profit of Rs 1 bn (up 51.2% YoY). Sales on the other hand came in at Rs 5 bn (up 12.5% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER 2017-18 Annual Report Analysis (Annual Result Update)

Jan 1, 2019 | Updated on Jan 1, 2019

Here's an analysis of the annual report of PFIZER for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PFIZER. Also includes updates on the valuation of PFIZER.

PFIZER Announces Quarterly Results (2QFY19); Net Profit Down 13.8% (Quarterly Result Update)

Nov 15, 2018 | Updated on Nov 15, 2018

For the quarter ended September 2018, PFIZER has posted a net profit of Rs 958 m (down 13.8% YoY). Sales on the other hand came in at Rs 5 bn (down 9.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

ORCHID PHARMA LTD Announces Quarterly Results (4QFY18); Net Profit Up 50.8% (Quarterly Result Update)

Aug 24, 2018 | Updated on Aug 24, 2018

For the quarter ended March 2018, ORCHID PHARMA LTD has posted a net profit of Rs 924 m (up 50.8% YoY). Sales on the other hand came in at Rs 2 bn (down 24.0% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

More Views on News

Most Popular

7 Stocks to Profit from Sensex 100,000(The 5 Minute Wrapup)

Feb 4, 2019

Tanushree Banerjee explains everything you need to know about the Rebirth of India and Sensex 100,000.

The RCom Bankruptcy: 5 Lessons for Smallcap Investors(Profit Hunter)

Feb 7, 2019

Managements of companies can create or ruin their fortunes. Why is management quality such an important factor in valuing businesses? Read on to find out...

Here's What the Biggest 'Rebirth of India' Investors are Doing(The 5 Minute Wrapup)

Feb 5, 2019

A roundtable on the 18th of January 2019 had investors with billions of dollars of investment kitty.

The One Real Estate Stock to Buy Now(The 5 Minute Wrapup)

Feb 13, 2019

The real estate sector is ready to make a comeback. This is the stock to consider buying.

Do You Have the Stomach to Survive a Small Cap Crash?(Profit Hunter)

Feb 5, 2019

While selecting good businesses is relatively easy task in a bearish phase, where most people fail is in having enough patience to hold the quality stocks until recovery.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Feb 15, 2019 (Close)

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS